SPP1 and glaucoma: The combination of GAS6 and SPP1 increased the AUCs to 76.1% and 68.7% for discriminating glaucoma patients from ICL or from cataracts patients, respectively (Figure 4C), with a sensitivity of 65.6%, and a specificity of 87.7% and 88.5%, respectively.